26 Abilify Gambling Lawsuits Join MDL In The Northern Florida Federal Court

Print

Abilify Gambling Lawsuits Allege The Antipsychotic Medication Causes Compulsive Gambling And Other Impulse Control Disorders.

abilify-compulsive-gambling-lawsuit-side-effects-lawsuits-bottleMore than 20 new Abilify gambling lawsuits have been filed into the Abilify MDL in the past two months. The multidistrict litigation (MDL) was established for Abilify lawsuits alleging compulsive behavior problems develop after taking the antipsychotic medication. The number of Abilify gambling lawsuits has more than doubled since the U.S. Judicial Panel on Multidistrict Litigation (JPML) transferred 22 Abilify gambling lawsuits to the U.S. District Court, Northern District of Florida on October 3. (In Re: Abilify (Aripiprazole) Products Liability Litigation – MDL 2734)

The JPML’s statistics report for MDLs show Abilify gambling complaints rose from 22 in October to 48 as of December 15. In transferring the federal Abilify lawsuits, the judicial panel explained that consolidating the Abilify claims for coordinated pretrial proceedings will eliminate duplicative discovery, inconsistent pretrial rulings and conserve the resources of the parties and the Court. The Abilify lawsuits name Otsuka Pharmaceuticals and Bristol-Myers Squibb, which makes and markets Abilify, as defendants. The complaints allege that Abilify was defectively designed or manufactured, and the defendants knew or should have known that Abilify can cause compulsive gambling behaviors in individuals who are prescribed the medication. The plaintiffs also allege that the defendants failed to provide adequate instructions and warnings with Abilify. (In Re: Abilify (Aripiprazole) Products Liability Litigation – MDL 2734)

“We anticipate even more lawsuits to be added to the Abilify MDL in the near future,” says Wright & Schulte LLC.

Wright & Schulte LLC is offering free Abilify gambling lawsuit evaluations to individuals who allegedly sustained significant financial losses and other damages due to an Abilify gambling addiction or other impulse control problems that may be linked to the medication. Please visit our website at www.yourlegalhelp.com or call 1-800-399-0795 to learn more about your potential legal recourse.

Abilify (aripiprazole) is an atypical antipsychotic approved by the U.S. Food and Drug Administration (FDA) in November 2002 to treat schizophrenia, bipolar disorder, Tourette’s disorder, and irritability associated with autistic disorder. According to the FDA, aripiprazole is in a drug class of medications called partial dopamine receptor agonists and works somewhat differently than other medicines in its class. Most atypical antipsychotics more fully block dopamine receptors in the brain, while aripiprazole only partially blocks the activity of these receptors.

Aripiprazole is available under the brand names Abilify, Abilify Maintena, Aristada, and also as generics.
[fda.gov/Drugs/DrugSafety/ucm498662.htm, FDA, May 3, 2016]

In May, the FDA warned that uncontrollable urges to gamble, binge eat, shop, and have sex had been reported with the use of Abilify. However, these compulsive behaviors stopped when users stopped taking Abilify or their dose was reduced. While the gambling warning was already reported as a side effect on the current aripiprazole drug labels, the FDA added the other compulsive behaviors to the drug labels and the patient medication guides for all aripiprazole products.

Court documents indicate that one of the Abilify gambling complaints filed in the MDL was on behalf of an Ohio man who was prescribed the medication around May 2013 and began “compulsively gambling shortly thereafter.” According to the lawsuit, when the man stopped taking Abilify in August 2014, his compulsive gambling habit also stopped. However, in November 2014, he realized that he had lost $75,000 while gambling. The Abilify complaint accuses Otsuka Pharmaceuticals and Bristol-Myers Squibbof of failing to warn Abilify users and prescribers in the United States about the risks of gambling and other compulsive behaviors associated with the drug. (Case No. 3:16-cv-00632, In Re: Abilify (Aripiprazole) Products Liability Litigation – MDL 2734)

About Wright & Schulte LLC And Filing An Abilify Gambling Lawsuit

Wright & Schulte LLC is an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, do not hesitate to contact Wright & Schulte LLC today. Free Abilify gambling lawsuit case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

Contact:
Wright & Schulte LLC
865 S. Dixie Dr.
Vandalia, Ohio 45377
1-800-399-0795
www.yourlegalhelp.com

This entry was posted in Wright & Schulte Lawsuit News. Bookmark the permalink.